COVID-19-Associated Pulmonary Aspergillosis, March-August 2020 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Emerging Infectious Diseases Année : 2021

COVID-19-Associated Pulmonary Aspergillosis, March-August 2020

Iker Falces-Romero
Irma Hoyo
  • Fonction : Auteur
Azucena Rodriguez-Guardado
  • Fonction : Auteur
Ertan Sal
  • Fonction : Auteur
  • PersonId : 1100594

Résumé

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion caused by this virus and the subsequent administration of drugs directed at the immune system, we anticipated that patients might experience fungal superinfection. We collected data from 186 patients who had coronavirus disease-associated pulmonary aspergillosis (CAPA) worldwide during March-August 2020. Overall, 182 patients were admitted to the intensive care unit (ICU), including 180 with acute respiratory distress syndrome and 175 who received mechanical ventilation. CAPA was diagnosed a median of 10 days after coronavirus disease diagnosis. Aspergillus fumigatus was identified in 80.3% of patient cultures, 4 of which were azole-resistant. Most (52.7%) patients received voriconazole. In total, 52.2% of patients died; of the deaths, 33.0% were attributed to CAPA. We found that the cumulative incidence of CAPA in the ICU ranged from 1.0% to 39.1%.
Fichier principal
Vignette du fichier
20-4895.pdf (1.47 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03245103 , version 1 (01-06-2021)

Licence

Paternité

Identifiants

Citer

Jon Salmanton-Garcia, Rosanne Sprute, Jannik Stemler, Michele Bartoletti, Damien Dupont, et al.. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerging Infectious Diseases, 2021, 27 (4), pp.1077-1086. ⟨10.3201/eid2704.204895⟩. ⟨hal-03245103⟩
48 Consultations
74 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More